Valuation: AbbVie Inc.

Market Cap 433B 376B 351B 323B 608B 41,283B 619B 4,144B 1,623B 20,587B 1,627B 1,591B 67,904B P/E 2026 *
33.4x
P/E 2027 * 23.5x
Enterprise Value 489B 425B 396B 364B 686B 46,569B 698B 4,674B 1,831B 23,223B 1,835B 1,795B 76,599B EV / Sales 2026 *
7.23x
EV / Sales 2027 * 6.56x
Free-Float
95.71%
Yield 2026 *
2.82%
Yield 2027 * 2.95%
1 day-2.33%
1 week-4.60%
Current month-2.33%
1 month-6.12%
3 months+18.64%
6 months+8.61%
Current year+7.27%
1 week 244.44
Extreme 244.44
267.47
1 month 243.07
Extreme 243.07
267.47
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 69 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

62 0.0000%
6/30/26 Free

Director

134 0.0000%
5/8/26 Free

Director

1,118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-4.60%+25.55%+64.44% 433B
-2.39%-6.36%+47.10%+149.66% 1T
-0.76%-4.34%+52.04%+49.09% 613B
+0.06%-3.02%+39.92%+34.62% 350B
+0.11%-4.37%+31.85%+40.00% 292B
+2.03%-9.54%+5.12%+7.30% 239B
+1.49%-8.35%-1.79%-42.09% 206B
-1.63%+0.69%+27.62%+64.23% 204B
+0.72%+0.48%+15.88%+73.64% 163B
+0.08%+1.46%+6.56%-28.49% 143B
Average +0.33%-3.30%+24.98%+41.24% 364.31B
Weighted average by Cap. +0.15%-4.09%+33.86%+67.41%

Financials

2026 *2027 *
Net sales 67.58B 58.73B 54.84B 50.34B 94.92B 6,442B 96.57B 647B 253B 3,212B 254B 248B 10,595B 73.02B 63.46B 59.24B 54.39B 103B 6,960B 104B 699B 274B 3,471B 274B 268B 11,447B
Net income 15.17B 13.18B 12.31B 11.3B 21.3B 1,446B 21.67B 145B 56.83B 721B 56.97B 55.7B 2,378B 18.29B 15.9B 14.84B 13.63B 25.7B 1,744B 26.14B 175B 68.55B 870B 68.72B 67.2B 2,868B
Net Debt 55.46B 48.2B 45B 41.31B 77.89B 5,286B 79.25B 531B 208B 2,636B 208B 204B 8,694B 46.16B 40.12B 37.46B 34.39B 64.84B 4,400B 65.97B 442B 173B 2,194B 173B 170B 7,237B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-08-03 $245.10 -2.33% 7,435,935
26-07-31 $250.94 -2.51% 7,258,176
26-07-30 $257.41 -2.24% 6,406,625
26-07-29 $263.30 +0.04% 5,563,736
26-07-28 $263.20 +2.45% 7,060,442
Trader
Investor
Global
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
245.10USD
Average target price
272.14USD
Spread / Average Target
+11.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock